209 related articles for article (PubMed ID: 28493412)
1. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
[TBL] [Abstract][Full Text] [Related]
2. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
3. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma.
Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T
J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312
[TBL] [Abstract][Full Text] [Related]
4. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents.
Shimose S; Kubo T; Fujimori J; Furuta T; Ochi M
J Orthop Sci; 2014 Nov; 19(6):997-1003. PubMed ID: 25100572
[TBL] [Abstract][Full Text] [Related]
5. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
6. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
8. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer.
Mikah P; Krabbe LM; Eminaga O; Herrmann E; Papavassilis P; Hinkelammert R; Semjonow A; Schrader AJ; Boegemann M
BMC Cancer; 2016 Mar; 16():214. PubMed ID: 26975660
[TBL] [Abstract][Full Text] [Related]
10. Relationships between serum biomarker levels and clinical presentation of human osteosarcomas.
Limmahakhun S; Pothacharoen P; Theera-Umpon N; Arpornchayanon O; Leerapun T; Luevitoonvechkij S; Pruksakorn D
Asian Pac J Cancer Prev; 2011; 12(7):1717-22. PubMed ID: 22126551
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
12. Identification of Biomarkers for Osteosarcoma Based on Integration Strategy.
Bao J; Song Z; Song C; Wang Y; Li W; Mai W; Shi Q; Yu H; Ni L; Liu Y; Lu X; He C; Chen L; Qu G
Med Sci Monit; 2020 Mar; 26():e920803. PubMed ID: 32173717
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
14. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.
Jin Y; Yuan MQ; Chen JQ; Zhang YP
Clinics (Sao Paulo); 2015 Apr; 70(4):264-72. PubMed ID: 26017793
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data.
Ren HY; Sun LL; Li HY; Ye ZM
Biomed Res Int; 2015; 2015():160835. PubMed ID: 26618165
[TBL] [Abstract][Full Text] [Related]
16. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma.
Yu H; Yu J; Ren Y; Yang Y; Xiao X
PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014
[TBL] [Abstract][Full Text] [Related]
17. Serum bone-specific alkaline phosphatase as a biomarker for osseous metastases in patients with malignant carcinomas: a systematic review and meta-analysis.
Du WX; Duan SF; Chen JJ; Huang JF; Yin LM; Tong PJ
J Cancer Res Ther; 2014 Nov; 10 Suppl():C140-3. PubMed ID: 25450272
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Hum Pathol; 1998 Oct; 29(10):1050-5. PubMed ID: 9781640
[TBL] [Abstract][Full Text] [Related]
19. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
